Alison E Suarez, MD | |
5645 Main St, Flushing, NY 11355-5045 | |
(718) 670-1426 | |
(516) 437-4167 |
Full Name | Alison E Suarez |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Experience | 20 Years |
Location | 5645 Main St, Flushing, New York |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174716278 | NPI | - | NPPES |
02947744 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 245110 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Optum Urgent Care Pllc | 8628299518 | 88 |
Optum Medical Care Pc | 9931013240 | 997 |
News Archive
Today's headlines include reports from the states about action on public employee benefit reforms and Planned Parenthood funding.
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
What parents make available for their children to eat can contribute to an obesity-prone home food environment, according to researchers at Kansas State University.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that it has entered into a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Commerce Court Small Cap Value Fund, Ltd. over an approximately 18-month period. Poniard is not obligated to utilize any of the facility and remains free to enter into other financing transactions.
› Verified 7 days ago
Entity Name | Optum Medical Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982643003 PECOS PAC ID: 9931013240 Enrollment ID: O20031119000321 |
News Archive
Today's headlines include reports from the states about action on public employee benefit reforms and Planned Parenthood funding.
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
What parents make available for their children to eat can contribute to an obesity-prone home food environment, according to researchers at Kansas State University.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that it has entered into a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Commerce Court Small Cap Value Fund, Ltd. over an approximately 18-month period. Poniard is not obligated to utilize any of the facility and remains free to enter into other financing transactions.
› Verified 7 days ago
Entity Name | Prohealth Care Associates Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275596280 PECOS PAC ID: 4486544186 Enrollment ID: O20040317000468 |
News Archive
Today's headlines include reports from the states about action on public employee benefit reforms and Planned Parenthood funding.
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
What parents make available for their children to eat can contribute to an obesity-prone home food environment, according to researchers at Kansas State University.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that it has entered into a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Commerce Court Small Cap Value Fund, Ltd. over an approximately 18-month period. Poniard is not obligated to utilize any of the facility and remains free to enter into other financing transactions.
› Verified 7 days ago
Entity Name | North Shore - Lij Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Today's headlines include reports from the states about action on public employee benefit reforms and Planned Parenthood funding.
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
What parents make available for their children to eat can contribute to an obesity-prone home food environment, according to researchers at Kansas State University.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that it has entered into a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Commerce Court Small Cap Value Fund, Ltd. over an approximately 18-month period. Poniard is not obligated to utilize any of the facility and remains free to enter into other financing transactions.
› Verified 7 days ago
Entity Name | Optum Urgent Care Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285975797 PECOS PAC ID: 8628299518 Enrollment ID: O20141017000598 |
News Archive
Today's headlines include reports from the states about action on public employee benefit reforms and Planned Parenthood funding.
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
What parents make available for their children to eat can contribute to an obesity-prone home food environment, according to researchers at Kansas State University.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that it has entered into a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Commerce Court Small Cap Value Fund, Ltd. over an approximately 18-month period. Poniard is not obligated to utilize any of the facility and remains free to enter into other financing transactions.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Alison E Suarez, MD 1981 Marcus Ave, Suite 208, New Hyde Park, NY 11042-1038 Ph: (718) 670-1651 | Alison E Suarez, MD 5645 Main St, Flushing, NY 11355-5045 Ph: (718) 670-1426 |
News Archive
Today's headlines include reports from the states about action on public employee benefit reforms and Planned Parenthood funding.
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
What parents make available for their children to eat can contribute to an obesity-prone home food environment, according to researchers at Kansas State University.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that it has entered into a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Commerce Court Small Cap Value Fund, Ltd. over an approximately 18-month period. Poniard is not obligated to utilize any of the facility and remains free to enter into other financing transactions.
› Verified 7 days ago
Diane M Sixsmith, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 56-45 Main St, New York Hospital Medical Center Of Queens Emergency De, Flushing, NY 11355 Phone: 718-670-1231 Fax: 516-437-4167 | |
Mark Guevorkian, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-2000 | |
Dr. Jamie Alison Edelstein, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 56-45 Main Street, Flushing, NY 11355 Phone: 718-670-1100 | |
David Michael Pinter, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 14001 Jewel Ave Apt 2, Flushing, NY 11367 Phone: 718-309-3202 | |
Brenda Lee-hao Liu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 56-45 Main Street, New York Hospital Medical Center Of Queens - Emergency, Flushing, NY 11355 Phone: 718-670-1231 Fax: 610-617-6280 | |
David Barlas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 56-45 Main Street, New York Hospital Medical Center Of Queens - Emergency, Flushing, NY 11355 Phone: 718-670-1231 Fax: 610-617-6280 | |
Mitchell Melikhov-sosin, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 56-45 Main Street, Flushing, NY 11355 Phone: 718-661-7305 |